Avance Biosciences offers both Sanger sequencing to support our clients worldwide for their drug development and manufacturing activities. The FDA continues to require the completion of two-fold double stranded Sanger sequencing for genomic identity of biologics produced from cell lines via integrated or non-integrated vectors.
With more than twenty years of experience and sequencing knowledge, Avance Biosciences experienced scientists can execute DNA sequencing techniques tailored to meet our clients’ needs. We are specialized in offering GLP and cGMP compliant Sanger sequencing services.
Genomics & Biological Services
All Avance Services Include
Experienced scientists functioning as project managers or study directors
Controlled laboratory environment to prevent cross-contamination
Rigorous sample tracking and handling procedures to prevent mistakes and cross-contamination
Methods validated per ICH GLP/GMP guidelines – also research grade testing available
Projects customized and tailored to suit your needs
Independent quality unit assuring regulatory compliance
Transparent process flow and weekly report on project progress
Professional project reports ready for regulatory filing
Fast turn-around time & Competitive pricing